Reports
-
Michigan Did Not Effectively Monitor Home Heating Benefits Provided Under the Low-Income Home Energy Assistance Program
-
Department of Health and Human Services’ Hybrid Work Environment as of May 2024
-
Part D Plans Generally Include Drugs Commonly Used by Dual-Eligible Enrollees: 2025
-
2024 Performance Data for the Senior Medicare Patrol Projects
-
Maine Could Better Ensure That Intermediate Care Facilities for Individuals With Intellectual Disabilities Comply With Federal Requirements for Life Safety, Emergency Preparedness, and Infection Control
-
Eleven of Thirty Selected Hospitals Did Not Comply With Terms and Conditions and Federal Requirements for Expending Provider Relief Fund Payments
-
Ten of Thirty Selected Nursing Facilities Did Not Comply or May Not Have Complied With Terms and Conditions and Federal Requirements for Expending Provider Relief Fund Payments
-
NIH Recipients Conducting Biospecimen Research: Gaps in Emergency Planning and Reporting
-
CMS Use of Staffing Data To Inform State Oversight of Nursing Homes
-
HHS’s Grant Payment System Lacked Effective Internal Controls To Prevent $7.8 Million in Fraud, and HHS Has Begun Taking Corrective Actions To Reduce Fraud Risk
-
FDA Food Safety Inspections of Domestic Food Facilities
-
California Medicaid Fraud Control Unit: 2023 Inspection
-
Minnesota Could Better Ensure That Childcare Assistance Providers Comply With Attendance Requirements
-
Medicare Payments for Evaluation and Management Services Provided on the Same Day as Eye Injections Were at Risk for Noncompliance With Medicare Requirements
-
Department of Health and Human Services Met Many Requirements, but It Did Not Fully Comply With the Payment Integrity Information Act of 2019 and Applicable Improper Payment Guidance for Fiscal Year 2024
-
Maryland Did Not Comply With Federal Waiver and State Requirements at 20 Adult Day Care Facilities Audited
-
CMS Is Not Systematically Tracking Whether States Return Federal Shares of Medicaid Managed Care Remittances
-
Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the Fourth Quarter of 2024
-
Most Medicare Part D Plans’ Formularies Included Humira Biosimilars for 2025
-
Risk Assessment of the Administration for Community Living’s Travel Card Program for Fiscal Year 2022